Skip to main content

Advertisement

Open Peer Review Reports for: P-glycoprotein and breast cancer resistance protein in acute myeloid leukaemia cells treated with the Aurora-B Kinase Inhibitor barasertib-hQPA

Back to article

Pre-publication versions of this article are available by contacting info@biomedcentral.com.

Original Submission
1 Mar 2011 Submitted Original manuscript
2 Mar 2011 Author responded Author comments - Martin Grundy
Resubmission - Version 2
2 Mar 2011 Submitted Manuscript version 2
1 Apr 2011 Reviewed Reviewer Report - Gareth Gerrard
1 Apr 2011 Reviewed Reviewer Report - Elisabeth Walsby
20 Apr 2011 Author responded Author comments - Martin Grundy
Resubmission - Version 3
20 Apr 2011 Submitted Manuscript version 3
5 May 2011 Reviewed Reviewer Report - Gareth Gerrard
10 May 2011 Reviewed Reviewer Report - Elisabeth Walsby
18 May 2011 Author responded Author comments - Martin Grundy
Resubmission - Version 4
18 May 2011 Submitted Manuscript version 4
14 Jun 2011 Author responded Author comments - Martin Grundy
Resubmission - Version 5
14 Jun 2011 Submitted Manuscript version 5
15 Jun 2011 Author responded Author comments - Martin Grundy
Resubmission - Version 6
15 Jun 2011 Submitted Manuscript version 6
Publishing
16 Jun 2011 Editorially accepted
16 Jun 2011 Article published 10.1186/1471-2407-11-254

How does Open Peer Review work?

Open peer review is a system where authors know who the reviewers are, and the reviewers know who the authors are. If the manuscript is accepted, the named reviewer reports are published alongside the article. Pre-publication versions of the article are available by contacting info@biomedcentral.com.

You can find further information about the peer review system here.

Advertisement